Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1974 2
1976 1
1977 1
1978 1
1979 1
1980 1
1981 1
1982 2
1983 1
1984 6
1985 7
1986 15
1987 6
1988 12
1989 12
1990 8
1991 12
1992 9
1993 18
1994 30
1995 18
1996 19
1997 18
1998 25
1999 30
2000 32
2001 42
2002 42
2003 37
2004 30
2005 41
2006 47
2007 46
2008 53
2009 28
2010 43
2011 41
2012 45
2013 43
2014 39
2015 36
2016 47
2017 37
2018 39
2019 39
2020 40
2021 49
2022 38
2023 43
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,142 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive map of molecular drug targets.
Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, Overington JP. Santos R, et al. Among authors: karlsson a. Nat Rev Drug Discov. 2017 Jan;16(1):19-34. doi: 10.1038/nrd.2016.230. Epub 2016 Dec 2. Nat Rev Drug Discov. 2017. PMID: 27910877 Free PMC article. Review.
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials.
Whitley J, Zwolinski C, Denis C, Maughan M, Hayles L, Clarke D, Snare M, Liao H, Chiou S, Marmura T, Zoeller H, Hudson B, Peart J, Johnson M, Karlsson A, Wang Y, Nagle C, Harris C, Tonkin D, Fraser S, Capiz L, Zeno CL, Meli Y, Martik D, Ozaki DA, Caparoni A, Dickens JE, Weissman D, Saunders KO, Haynes BF, Sempowski GD, Denny TN, Johnson MR. Whitley J, et al. Among authors: karlsson a. Transl Res. 2022 Apr;242:38-55. doi: 10.1016/j.trsl.2021.11.009. Epub 2021 Dec 4. Transl Res. 2022. PMID: 34871810 Free PMC article. Review.
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
Lehtiö J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, Umer HM, Mermelekas G, Pirmoradian M, Jönsson M, Brunnström H, Brustugun OT, Purohit KP, Cunningham R, Foroughi Asl H, Isaksson S, Arbajian E, Aine M, Karlsson A, Kotevska M, Gram Hansen C, Drageset Haakensen V, Helland Å, Tamborero D, Johansson HJ, Branca RM, Planck M, Staaf J, Orre LM. Lehtiö J, et al. Among authors: karlsson a. Nat Cancer. 2021 Nov;2(11):1224-1242. doi: 10.1038/s43018-021-00259-9. Epub 2021 Nov 22. Nat Cancer. 2021. PMID: 34870237 Free PMC article.
A prolonged innate systemic immune response in COVID-19.
Ekstedt S, Piersiala K, Petro M, Karlsson A, Kågedal Å, Kumlien Georén S, Cardell LO. Ekstedt S, et al. Among authors: karlsson a. Sci Rep. 2022 Jun 15;12(1):9915. doi: 10.1038/s41598-022-13986-5. Sci Rep. 2022. PMID: 35705573 Free PMC article.
Orofacial dysfunction after stroke-A multidisciplinary approach.
Skott P, Åkesson E, Johansson K, Dalum J, Persson E, Karlsson Å, Seiger Å, McAllister A, Sandborgh-Englund G. Skott P, et al. Among authors: karlsson a. Gerodontology. 2023 Sep 11. doi: 10.1111/ger.12713. Online ahead of print. Gerodontology. 2023. PMID: 37694276
From linear to metric functional analysis.
Karlsson A. Karlsson A. Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):e2107069118. doi: 10.1073/pnas.2107069118. Proc Natl Acad Sci U S A. 2021. PMID: 34244434 Free PMC article.
High-performance fixed-bed in situ mass analyzer-ISMA.
Karlsson A, Lødeng R, Haugholt KH, Myhrvold E, Plassen M, Thorshaug K. Karlsson A, et al. Rev Sci Instrum. 2023 Jun 1;94(6):065108. doi: 10.1063/5.0149970. Rev Sci Instrum. 2023. PMID: 37862540
A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects.
Hjalmarsson E, Hellkvist L, Karlsson A, Winquist O, Kumlien Georén S, Westin U, Cardell LO. Hjalmarsson E, et al. Among authors: karlsson a. J Investig Allergol Clin Immunol. 2023 Oct;33(5):362-372. doi: 10.18176/jiaci.0832. J Investig Allergol Clin Immunol. 2023. PMID: 37843385 Free article. Clinical Trial.
1,142 results